Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/28149
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBui, Dinh S-
dc.contributor.authorLodge, Caroline J-
dc.contributor.authorBurgess, John A-
dc.contributor.authorLowe, Adrian J-
dc.contributor.authorPerret, Jennifer L-
dc.contributor.authorBui, Minh Q-
dc.contributor.authorBowatte, Gayan-
dc.contributor.authorGurrin, Lyle-
dc.contributor.authorJohns, David P-
dc.contributor.authorThompson, Bruce R-
dc.contributor.authorHamilton, Garun S-
dc.contributor.authorFrith, Peter A-
dc.contributor.authorJames, Alan L-
dc.contributor.authorThomas, Paul S-
dc.contributor.authorJarvis, Deborah-
dc.contributor.authorSvanes, Cecilie-
dc.contributor.authorRussell, Melissa-
dc.contributor.authorMorrison, Stephen C-
dc.contributor.authorFeather, Iain-
dc.contributor.authorAllen, Katrina J-
dc.contributor.authorWood-Baker, Richard-
dc.contributor.authorHopper, John-
dc.contributor.authorGiles, Graham G-
dc.contributor.authorAbramson, Michael J-
dc.contributor.authorWalters, Eugene H-
dc.contributor.authorMatheson, Melanie C-
dc.contributor.authorDharmage, Shyamali C-
dc.date2018-
dc.date.accessioned2021-11-24T05:40:20Z-
dc.date.available2021-11-24T05:40:20Z-
dc.date.issued2018-07-
dc.identifier.citationThe Lancet. Respiratory medicine 2018; 6(7): 535-544en
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/28149-
dc.description.abstractLifetime lung function is related to quality of life and longevity. Over the lifespan, individuals follow different lung function trajectories. Identification of these trajectories, their determinants, and outcomes is important, but no study has done this beyond the fourth decade. We used six waves of the Tasmanian Longitudinal Health Study (TAHS) to model lung function trajectories measured at 7, 13, 18, 45, 50, and 53 years. We analysed pre-bronchodilator FEV1 z-scores at the six timepoints using group-based trajectory modelling to identify distinct subgroups of individuals whose measurements followed a similar pattern over time. We related the trajectories identified to childhood factors and risk of chronic obstructive pulmonary disease (COPD) using logistic regression, and estimated population-attributable fractions of COPD. Of the 8583 participants in the original cohort, 2438 had at least two waves of lung function data at age 7 years and 53 years and comprised the study population. We identified six trajectories: early below average, accelerated decline (97 [4%] participants); persistently low (136 [6%] participants); early low, accelerated growth, normal decline (196 [8%] participants); persistently high (293 [12%] participants); below average (772 [32%] participants); and average (944 [39%] participants). The three trajectories early below average, accelerated decline; persistently low; and below average had increased risk of COPD at age 53 years compared with the average group (early below average, accelerated decline: odds ratio 35·0, 95% CI 19·5-64·0; persistently low: 9·5, 4·5-20·6; and below average: 3·7, 1·9-6·9). Early-life predictors of the three trajectories included childhood asthma, bronchitis, pneumonia, allergic rhinitis, eczema, parental asthma, and maternal smoking. Personal smoking and active adult asthma increased the impact of maternal smoking and childhood asthma, respectively, on the early below average, accelerated decline trajectory. We identified six potential FEV1 trajectories, two of which were novel. Three trajectories contributed 75% of COPD burden and were associated with modifiable early-life exposures whose impact was aggravated by adult factors. We postulate that reducing maternal smoking, encouraging immunisation, and avoiding personal smoking, especially in those with smoking parents or low childhood lung function, might minimise COPD risk. Clinicians and patients with asthma should be made aware of the potential long-term implications of non-optimal asthma control for lung function trajectory throughout life, and the role and benefit of optimal asthma control on improving lung function should be investigated in future intervention trials. National Health and Medical Research Council of Australia; European Union's Horizon 2020; The University of Melbourne; Clifford Craig Medical Research Trust of Tasmania; The Victorian, Queensland & Tasmanian Asthma Foundations; The Royal Hobart Hospital; Helen MacPherson Smith Trust; and GlaxoSmithKline.en
dc.language.isoeng
dc.titleChildhood predictors of lung function trajectories and future COPD risk: a prospective cohort study from the first to the sixth decade of life.en
dc.typeJournal Articleen
dc.identifier.journaltitleThe Lancet. Respiratory medicineen
dc.identifier.affiliationInstitute for Breathing and Sleepen
dc.identifier.affiliationMonash Lung and Sleep, Monash Health, Melbourne, VIC, Australiaen
dc.identifier.affiliationDepartment of Medicine, School of Clinical Sciences, Monash University, Clayton, VIC, Australiaen
dc.identifier.affiliationAllergy and Lung Health Unit, School of Population and Global Health, The University of Melbourne, Melbourne, VIC, Australiaen
dc.identifier.affiliationDepartment of Medicine, School of Medicine, University of Tasmania, Hobart, TAS, Australiaen
dc.identifier.affiliationAllergy, Immunology & Respiratory Medicine, The Alfred Hospital, Melbourne, VIC, Australiaen
dc.identifier.affiliationDepartment of Respiratory Medicine, School of Medicine, Flinders University, Adelaide, SA, Australiaen
dc.identifier.affiliationDepartment of Pulmonary Physiology and Sleep Medicine, Sir Charles Gairdner Hospital, Nedlands, WA, Australiaen
dc.identifier.affiliationPrince of Wales Hospital Clinical School and School of Medical Sciences, Faculty of Medicine, University of New South Wales, Sydney, NSW, Australiaen
dc.identifier.affiliationDepartment of Respiratory Medicine, Gold Coast Hospital, Gold Coast, QLD, Australiaen
dc.identifier.affiliationMurdoch Childrens Research Institute, Royal Children's Hospital and University of Melbourne, Melbourne, VIC, Australiaen
dc.identifier.affiliationCancer Epidemiology Centre, Cancer Council Victoria, Melbourne, VIC, Australiaen
dc.identifier.affiliationDepartment of Epidemiology and Preventive Medicine, School of Public Health & Preventive Medicine, Monash University, Melbourne, VIC, Australiaen
dc.identifier.affiliationDepartment of Toxicology, Hanoi University of Pharmacy, Hanoi, Vietnamen
dc.identifier.affiliationNational Institute of Fundamental Studies, Kandy, Sri Lankaen
dc.identifier.affiliationDepartment of Thoracic Medicine, Royal Brisbane and Women's Hospital, Brisbane, QLD, Australiaen
dc.identifier.affiliationDiscipline of Medicine, University of Queensland, Brisbane, QLD, Australiaen
dc.identifier.affiliationCentre for International Health, Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norwayen
dc.identifier.affiliationDepartment of Epidemiology & Biostatistics, MRC-PHE Centre for Environment and Health, School of Public Health, Imperial College London, London, UKen
dc.identifier.affiliationDepartment of Occupational Medicine, Haukeland University Hospital, Bergen, Norwayen
dc.identifier.affiliationUK Respiratory Epidemiology and Public Health Group, National Heart and Lung Institute, Imperial College London, London, UKen
dc.identifier.pubmedurihttps://pubmed.ncbi.nlm.nih.gov/29628376/en
dc.identifier.doi10.1016/S2213-2600(18)30100-0en
dc.type.contentTexten
dc.identifier.orcid0000-0001-7034-0615en
dc.identifier.pubmedid29628376
local.name.researcherPerret, Jennifer L
item.languageiso639-1en-
item.openairetypeJournal Article-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.fulltextNo Fulltext-
item.grantfulltextnone-
item.cerifentitytypePublications-
crisitem.author.deptInstitute for Breathing and Sleep-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

24
checked on Nov 5, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.